OrbusNeich Celebrates Inauguration of Its Subsidiary PT Revass Utama Medika’s New Headquarters in Jakarta, Indonesia

(Indonesia, August 27, 2025) — OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (“PCI”) and percutaneous transluminal angioplasty (“PTA”) procedures, proudly announces the inauguration of the new headquarters of its subsidiary, PT Revass Utama Medika (“Revass”), in Jakarta, Indonesia, on August 26, 2025. This milestone underscores OrbusNeich’s commitment to advancing healthcare innovation in Indonesia.

The ceremony celebrating the launch of Revass’s new headquarters represents its evolution from a local distributor to a key player in a global network, embodying resilience and ambition. Revass plays a pivotal role in Indonesia’s healthcare sector, partnering with over 329 hospitals across 60 cities to supply medical devices. Since joining OrbusNeich in 2023, Revass has launched two subsidiaries, Kedung Artha Medika and Lumina, in 2024. It now serves 93% of Indonesia’s cath lab-equipped hospitals and has achieved around 40% year-to-date revenue increase as of June 2025. With rising demand for innovative medical technology, Revass leverages OrbusNeich’s global expertise to enhance its local market penetration.

Mr. David Chien, Chairman, Executive Director, and Chief Executive Officer of OrbusNeich commented, “The inauguration of Revass’s new headquarters in Jakarta is a testament to our strategic vision of expanding our global footprint while making a meaningful impact in Indonesia. This state-of-the-art facility embodies our commitment to quality, innovation, and service. By leveraging our advanced technologies and Revass’s deep market insights, we aim to deliver cutting-edge medical solutions that transform lives and strengthen Indonesia’s healthcare ecosystem.”

Mr. Andriatno Martono, President Director of Revass stated, “This modern headquarters marks a significant milestone in our mission to elevate healthcare standards in Indonesia. With OrbusNeich’s global support, enabling us to deliver advanced cardiovascular solutions that improve lives and contribute to a healthier Indonesia.”

The new headquarters symbolizes Revass’s evolution into a key player in OrbusNeich’s global network. Designed for collaboration and innovation, the facility will drive solutions for healthcare challenges, delivering better patient outcomes. This aligns with the Group’s long-term strategy of excellence in interventional medical devices and healthcare accessibility while meeting industry needs and enhancing the quality of life.

Speech of Ms. Denise Lau, Executive Director and Chief Operating Officer of OrbusNeich

Speech of Mr. Andriatno Martono, President Director of Revass

Officiating guests were: (left to right) Mr. Zidn Ilma Stakeholder of Revasss; Mr. Kuncoro Nugroho, Finance and Distribution Director of Revass; Mr. Andriatno Martono, President Director of Revass; Ms. Denise Lau, Executive Director and Chief Operating Officer of OrbusNeich; Mr. Jason Chen, Executive Director and Chief Financial Officer of OrbusNeich; Mr. Satriyo Hermawan, Sales Director of Revass; and Mr. Aditya Bagus, Operating Director of Revass

－ End －

About PT Revass Utama Medika
Founded in 2010, PT Revass Utama Medika is a company engaged in the distribution and marketing of cardiology intervention medical devices. The company has established a strong sales network spanning more than 30 major cities across the Indonesian archipelago. Beginning as an importer and distributor of OrbusNeich products, Revass has steadily expanded its business and presence in the Indonesian healthcare market. Following the majority acquisition by OrbusNeich in 2023, Revass further strengthened its position with the establishment of two subsidiaries, Lumina Utama Medika and Kedung Artha Medika, in 2024. With a vision to be a trusted and leading business partner, Revass remains committed to delivering quality healthcare solutions and advancing patient care in Indonesia.

For more information, please visit the Company’s official website: https://www.revassutamamedika.com/

About OrbusNeich Medical Group Holdings Limited
OrbusNeich is a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, our Group sells its products in more than 70 countries and regions worldwide. It is also actively expanding into structural heart disease. With an in-house R&D team boasting over 20 years of product development expertise, our Group has developed world-leading proprietary technologies.

For more information, please visit the Group’s official website: https://orbusneich.com/.